Is there a role for the use of biologics as steroid sparing agents in treating patients with ABPA who are intolerant to prednisone?  

Treatment for ABPA is generally guided by IgE levels and corticosteroids remain the main drug therapy regardless of classification in both people with cystic fibrosis (CF) and without. Limited treatment with antifungal therapy (itraconazole or voriconazole) is considered usually first in individuals...